Levofloxacin vs Pembrolizumab
Levofloxacin vs Pembrolizumab: Overview
This comparison examines the pharmacological differences between Levofloxacin and Pembrolizumab.
Mechanism of Action
Levofloxacin: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Pharmacokinetics
Half-life: Levofloxacin — 6-8 hours; Pembrolizumab — 26 days.
Chemical Properties
Molecular Formula: Levofloxacin — C18H20FN3O4.
Molecular Weight: Levofloxacin — 361.3680 g/mol.
Type: Levofloxacin — Small molecule; Pembrolizumab — Antibody.